Clinuvel Pharmaceuticals operates three fast-growing companies with significant insider ownership

As global markets go through a period of relative calm ahead of upcoming earnings reports and key economic indicators, investors continue to assess the landscape for solid investment opportunities. In this environment, growth stocks with high insider ownership can be particularly attractive, as significant insider ownership often signals confidence in the company’s future prospects from those who know it best.

Top 10 Growth Companies with High Insider Ownership

Name	Internal property	Profit growth
Hartshead Resources (ASX:HHR)	13.9%	86.3%
Cettire (ASX:CTT)	28.7%	26.7%
Good M-TecLTD (KOSDAQ:A441270)	17.3%	36.4%
Gaming Innovation Group (OB:GIG)	26.7%	36.9%
Seojin System Ltd (KOSDAQ:A178320)	27.9%	48.1%
Clinuvel Pharmaceuticals (ASX:CUV)	13.6%	26.6%
Calliditas Therapeutics (OM:CALTX)	11.6%	52.9%
The Oath (OB:VOW)	31.8%	97.6%
UTI (KOSDAQ:A179900)	34.1%	122.7%
EHang Holdings (NasdaqGM:EH)	32.8%	74.3%

Click here to see the full list of 1,450 stocks in our high-growth, high-insider stock screener.

We’ll take a look at some of the top picks from our selection tool.

Simply Wall St Growth Rating: ★★★★★★

Overview: Clinuvel Pharmaceuticals Limited is a biopharmaceutical company specializing in the development and commercialization of medicines for patients with genetic, metabolic and life-threatening diseases. It operates in Australia, Europe, the United States and Switzerland. It has a market capitalization of approximately A$0.76 billion.

Operations: The company’s revenues are mainly derived from the biopharmaceutical sector and total AUD 81.76 million.

Internal property: 13.6%

Clinuvel Pharmaceuticals, with a large insider stake, is poised for solid growth, with expected full-year earnings and revenue growth to outpace the Australian market. Recent management changes and innovative clinical trials in Parkinson’s disease underscore its strategic direction. Despite these prospects, it is crucial to closely monitor the effectiveness of new health applications and management changes to accurately assess future performance.

Simply Wall St Growth Rating: ★★★★★☆☆

Overview: Exclusive Networks SA is a global company specializing in cybersecurity of digital infrastructure with a market capitalization of approximately EUR 1.93 billion.

Operations: The company’s revenues come mainly from three geographical segments: APAC (EUR 420 million), EMEA (EUR 4.04 billion) and Americas (EUR 689 million).

Internal property: 13.2%

Exclusive Networks SA, while not a leader in high-insider growth companies, shows potential, with a projected annual profit growth of 28.4%, outperforming the French market’s 10.9%. Revenue is expected to grow at a rate of 14.4% per year, faster than the market average of 5.7%, though below the high-growth benchmark of 20%. Recent changes include appointing KPMG as auditor and forecasting sales growth of 10-12% for fiscal 2024, signaling strategic alignment and stable fiscal expectations.

Simply Wall St Growth Rating: ★★★★★☆☆

Overview: Persol Holdings Co., Ltd. operates globally, providing human resources services under the PERSOL brand, and has a market capitalization of approximately 555.86 billion yen.

Operations: The company’s revenue is primarily generated from human resources services (excluding BPO) at ¥575.80 billion, and from the Asia Pacific business at ¥412.77 billion. Additional revenue comes from the career services and technology segments, which amount to ¥128.28 billion and ¥102.38 billion, respectively. The BPO business also generates ¥110.80 billion.

Internal property: 11.8%

Persol Holdings Ltd., while not a standout among growth stocks with large insider ownership, shows promise. The company’s earnings are expected to grow 12% annually, beating the Japanese market’s forecast of 8.9%. However, revenue growth of 5.3% annually is modest compared to high-growth rates, but still exceeds the Japanese market’s 4.2%. Recent strategic moves include a significant share buyback program worth 20 billion yen, aimed at increasing shareholder returns through March 2025.

Key conclusions

Curious about other options?

This Simply Wall St article is for general information purposes only. Our commentary is based solely on historical data and analyst forecasts, and is based on an objective methodology. Our articles are not intended to be financial advice. It is not a recommendation to buy or sell stocks and does not take into account your objectives or financial situation. Our goal is to provide you with long-term, focused analysis based on fundamental data. Please note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any of the stocks mentioned. The analysis only includes shares directly held by insiders. It does not include shares held indirectly through other entities such as corporate and/or trusts. All projected revenue and earnings growth rates are provided as annual growth rates over a 1-3 year period.

Have feedback on this article? Concerned about the content? Contact us directly. Alternatively, send an email to [email protected]